Charley, now 22 years old and a college student in NYC, is our original inspiration. Over the past 18 years we have met many other children whose colorful personalities and intense passions deepen our resolve to end Duchenne.
If you weren't familiar with the term "clinical trials" before Covid-19 rocked our worlds, for sure you've heard it by now. Lesser known -- but equally…
When it comes to developing new medicines for Duchenne, creating good drugs is of course paramount. It is also critical, however, to design good trials…
Goal: improve future decision-making in the selection of drugs to advance to clinical trials in Duchenne muscular dystrophy President and COO Laura with our partners…
Innovative device could power smaller, faster trials for Duchenne muscular dystrophy and open clinical trial participation to broader range of patients A key focus…
The Duchenne Program at University of Massachusetts Medical School celebrated its first anniversary in July, and according to its founding director, pediatric neurologist Dr. Brenda…
